Literature DB >> 27784343

Patterns of association of chronic medical conditions and major depression.

S B Patten1, J V A Williams2, D H Lavorato2, J L Wang3, N Jetté4, T T Sajobi4, K M Fiest5, A G M Bulloch3.   

Abstract

AIMS: Age and sex-related patterns of association between medical conditions and major depressive episodes (MDE) are important for understanding disease burden, anticipating clinical needs and for formulating etiological hypotheses. General population estimates are especially valuable because they are not distorted by help-seeking behaviours. However, even large population surveys often deliver inadequate precision to adequately describe such patterns. In this study, data from a set of national surveys were pooled to increase precision, supporting more precise characterisation of these associations.
METHODS: The data were from a series of Canadian national surveys. These surveys used comparable sampling strategies and assessment methods for MDE. Chronic medical conditions were assessed using items asking about professionally diagnosed medical conditions. Individual-level meta-analysis methods were used to generate unadjusted, stratified and adjusted prevalence odds ratios for 11 chronic medical conditions. Random effects models were used in the meta-analysis. A procedure incorporating rescaled replicate bootstrap weights was used to produce 95% confidence intervals.
RESULTS: Overall, conditions characterised by pain and inflammation tended to show stronger associations with MDE. The meta-analysis uncovered two previously undescribed patterns of association. Effect modification by age was observed in varying degrees for most conditions. This effect was most prominent for high blood pressure and cancer. Stronger associations were found in younger age categories. Migraine was an exception: the strength of association increased with age, especially in men. Second, especially for conditions predominantly affecting older age groups (arthritis, diabetes, back pain, cataracts, effects of stroke and heart disease) confounding by age was evident. For each condition, age adjustment resulted in strengthening of the associations. In addition to migraine, two conditions displayed distinctive patterns of association. Age adjusted odds ratios for thyroid disease reflected a weak association that was only significant in women. In epilepsy, a similar strength of association was found irrespective of age or sex.
CONCLUSIONS: The prevalence of MDE is elevated in association with most chronic conditions, but especially those characterised by inflammation and pain. Effect modification by age may reflect greater challenges or difficulties encountered by young people attempting to cope with these conditions. This pattern, however, does not apply to migraine or epilepsy. Neurobiological changes associated with these conditions may offset coping-related effects, such that the association does not weaken with age. Prominent confounding by age for several conditions suggests that age adjustments are necessary in order to avoid underestimating the strength of these associations.

Entities:  

Keywords:  Depression; epidemiology; mood disorders; population survey; risk factors; unipolar

Mesh:

Year:  2016        PMID: 27784343      PMCID: PMC6999000          DOI: 10.1017/S204579601600072X

Source DB:  PubMed          Journal:  Epidemiol Psychiatr Sci        ISSN: 2045-7960            Impact factor:   6.892


  53 in total

1.  Psychiatric disorder in a sample of the general population with and without chronic medical conditions.

Authors:  K B Wells; J M Golding; M A Burnam
Journal:  Am J Psychiatry       Date:  1988-08       Impact factor: 18.112

2.  Long-term medical conditions and major depression in the Canadian population.

Authors:  S B Patten
Journal:  Can J Psychiatry       Date:  1999-03       Impact factor: 4.356

3.  Confounding and Simpson's paradox.

Authors:  S A Julious; M A Mullee
Journal:  BMJ       Date:  1994-12-03

Review 4.  The role of inflammation in depression: from evolutionary imperative to modern treatment target.

Authors:  Andrew H Miller; Charles L Raison
Journal:  Nat Rev Immunol       Date:  2016-01       Impact factor: 53.106

5.  Thyroid hormones and depression: the Health in Men study.

Authors:  Osvaldo P Almeida; Helman Alfonso; Leon Flicker; Graeme Hankey; S A Paul Chubb; Bu B Yeap
Journal:  Am J Geriatr Psychiatry       Date:  2011-09       Impact factor: 4.105

6.  Performance of the composite international diagnostic interview short form for major depression in a community sample.

Authors:  S B Patten; J Brandon-Christie; J Devji; B Sedmak
Journal:  Chronic Dis Can       Date:  2000

Review 7.  Risk factors for depression in community-treated epilepsy: systematic review.

Authors:  Cameron J Lacey; Michael R Salzberg; Wendyl J D'Souza
Journal:  Epilepsy Behav       Date:  2014-12-26       Impact factor: 2.937

Review 8.  Depression and cardiovascular disease: a clinical review.

Authors:  David L Hare; Samia R Toukhsati; Peter Johansson; Tiny Jaarsma
Journal:  Eur Heart J       Date:  2013-11-25       Impact factor: 29.983

Review 9.  Epidemiology of depression and diabetes: a systematic review.

Authors:  Tapash Roy; Cathy E Lloyd
Journal:  J Affect Disord       Date:  2012-10       Impact factor: 4.839

Review 10.  Depression and pain comorbidity: a literature review.

Authors:  Matthew J Bair; Rebecca L Robinson; Wayne Katon; Kurt Kroenke
Journal:  Arch Intern Med       Date:  2003-11-10
View more
  15 in total

Review 1.  Treatment failure in inflammatory arthritis: time to think about syndemics?

Authors:  Elena Nikiphorou; Heidi Lempp; Brandon A Kohrt
Journal:  Rheumatology (Oxford)       Date:  2019-09-01       Impact factor: 7.580

2.  Increased inflammation predicts nine-year change in major depressive disorder diagnostic status.

Authors:  Nur Hani Zainal; Michelle G Newman
Journal:  J Abnorm Psychol       Date:  2021-10-07

3.  Depression and Anxiety in patients undergoing Percutaneous Coronary Intervention for Acute Coronary Syndrome.

Authors:  Syed Fayaz Mujtaba; Jawaid Akbar Sial; Musa Karim
Journal:  Pak J Med Sci       Date:  2020 Jul-Aug       Impact factor: 1.088

4.  The role of gender and anxiety in the association between somatic diseases and depression: findings from three combined epidemiological studies in primary care.

Authors:  E Asselmann; J Venz; L Pieper; H-U Wittchen; D Pittrow; K Beesdo-Baum
Journal:  Epidemiol Psychiatr Sci       Date:  2017-11-09       Impact factor: 6.892

5.  Prevalence and Severity of Depression in a Pakistani Population with at least One Major Chronic Disease.

Authors:  Ansab Godil; Muhammad Saad Ali Mallick; Arsalan Majeed Adam; Amna Haq; Akash Khetpal; Razna Afzal; Maliha Salim; Naureen Shahid
Journal:  J Clin Diagn Res       Date:  2017-08-01

6.  Comparing the self-perceived quality of life of multimorbid patients and the general population using the EQ-5D-3L.

Authors:  Alexandra A N'Goran; Anouk Déruaz-Luyet; Dagmar M Haller; Andreas Zeller; Thomas Rosemann; Sven Streit; Lilli Herzig
Journal:  PLoS One       Date:  2017-12-19       Impact factor: 3.240

Review 7.  A narrative literature review of depression following traumatic brain injury: prevalence, impact, and management challenges.

Authors:  Shannon B Juengst; Raj G Kumar; Amy K Wagner
Journal:  Psychol Res Behav Manag       Date:  2017-06-14

8.  Identification and Treatment Optimization of Comorbid Depression in Rheumatoid Arthritis.

Authors:  Mellissa H Withers; Louella T Gonzalez; George A Karpouzas
Journal:  Rheumatol Ther       Date:  2017-08-16

9.  Depression-related weight change and incident diabetes in a community sample.

Authors:  Eva Graham; Tristan Watson; Sonya S Deschênes; Kristian B Filion; Mélanie Henderson; Sam Harper; Laura C Rosella; Norbert Schmitz
Journal:  Sci Rep       Date:  2021-06-30       Impact factor: 4.379

10.  Gathering Opinions on Depression Information Needs and Preferences: Samples and Opinions in Clinic Versus Web-Based Surveys.

Authors:  Matthew T Bernstein; John R Walker; Kathryn A Sexton; Alan Katz; Brooke E Beatie
Journal:  JMIR Ment Health       Date:  2017-04-24
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.